Regenesis Biomedical, Inc.
Regenesis Biomedical, Inc. (Regenesis Biomedical) is a privately-held medical device manufacturing company. The company is principally engaged in the development and marketing of noninvasive regenerative medicine products. The company has developed and patented the provant wound therapy system based on the proprietary cell proliferation induction (CPI) technology platform. Provant is a compact noninvasive painless wound healing system that uses a radiofrequency signal to provoke a genetic sequence in critical skin cells. The company also provides training for its business users. In addition, Regenesis Biomedical also arranges medical conferences on wound care management and other related topics. The company is headquartered at Scottsdale in Arizona, the US.